CHICAGO, Dec. 10 /PRNewswire/ -- Corbett Accel Healthcare Group has selected Elisa Cooper-Broski, a 30-year agency veteran, to serve as its new Executive Vice President and Chief Marketing Officer (CMO). Cooper-Broski will direct Corbett Accel's business development strategy, lead the brand-building efforts for the company's five business units in conjunction with the business unit leaders, and reinforce its competitive position in the marketplace. Cooper-Broski will be based in Corbett Accel's New York office and will report directly to Scott D. Cotherman, Chief Executive Officer.
"The CMO role is relatively unknown in pharmaceutical advertising," noted Cotherman. "We are one of the first to identify the value a chief marketing officer brings to an organization. Elisa Cooper-Broski's extensive knowledge of the pharmaceutical industry, along with her multi-faceted experience, will be invaluable as we advance our integrated business development strategy."
Cooper-Broski has a proven track record in building global brands, directing teams, and identifying and winning new business. She brings nearly 30 years experience in turning agencies into high-performance companies. She has succeeded in elevating GSW New York's presence in the East Coast, and had been highly instrumental in building this agency's business. Cooper-Broski has served in other leadership positions that include: Saatchi & Saatchi Healthcare (formerly Klemtner Advertising); CommonHealth USA; and NCI Advertising (formerly Rolf Werner Rosenthal). Prior to joining Corbett Accel, Cooper-Broski was President and Chief Branding Officer for Bruce Leeb & Company, a privately held healthcare advertising agency. An accomplished creative strategist and speaker, Cooper-Broski has presented at national conferences and served as a thought leader in various publications.
"Corbett Accel has a strong reputation as an organization with a successfully established supra-culture, one that attracts and nurtures the most creative and strategic talent in all disciplines," said Cooper-Broski. "In this environment, my role as CMO will strengthen the overall impact of Corbett Accel and its business units in the pharmaceutical industry as a communications company that delivers visionary results with substantial and beneficial outcomes. I am delighted to play such an integral role in this outstanding culture and to work with such passionate leaders."
Corbett Accel Healthcare Group (http://www.corbettaccel.com) is one of the largest healthcare communications companies in the world and a part of Omnicom Group Inc. (NYSE: OMC) (http://www.omnicomgroup.com). Corbett Accel business units include Corbett Worldwide Healthcare Communications and Surge Worldwide Healthcare Communications, both of which offer professional healthcare advertising, branding and promotions; Iris Global Clinical Trial Solutions; Kinect, a full-service interactive agency; and Accel Health, a promotional medical education agency.
Omnicom is a leading global advertising, marketing and corporate communications company. Omnicom's branded networks and numerous specialty firms provide advertising, strategic media planning and buying, digital and interactive, direct and promotional marketing, public relations and other specialty communications services to over 5,000 clients in more than 100 countries.
|SOURCE Corbett Accel Healthcare Group|
Copyright©2007 PR Newswire.
All rights reserved